PAM
MBVX

Panagora Asset Management’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Panagora Asset Management’s Portfolio MBVX Stock Details MBVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-33,958
Closed -$2K – 2814
2019
Q2 		$2K Hold
33,958
– – ﹤0.01% 2549
2019
Q1 		$1K Sell
33,958
-2,463
-7% -$73 ﹤0.01% 2496
2018
Q4 		$4K Buy
36,421
+10,039
+38% +$1.1K ﹤0.01% 2391
2018
Q3 		$11K Buy
+26,382
New +$21.8K ﹤0.01% 2302

Panagora Asset Management's MBVX Position: Q3 2019 in Review

Panagora Asset Management sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q3 2019, closing a stake of 33,958 shares — an estimated $2K sold.

Panagora Asset Management first reported a position in MBVX in Q3 2018 and held it in 4 quarters. The position peaked at $11K in Q3 2018. 0 funds tracked by Wall St. Rank hold MBVX as of Q3 2019.

  • Panagora Asset Management reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 33,958 MABVAX THERAPEUTICS HLDGS INC shares in Q3 2019, an estimated $2K.
  • Panagora Asset Management first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q3 2018 and held it in 4 quarters.
  • Panagora Asset Management's MABVAX THERAPEUTICS HLDGS INC position peaked at $11K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.